What is the role of rituximab in the treatment of rheumatoid arthritis?
Authors:
- Fabiola AtzeniFAFabiola Atzeni
- Andrea DoriaADAndrea Doria
- Turiel MaurizioTMTuriel Maurizio
- Piercarlo Sarzi-PuttiniPSPiercarlo Sarzi-Puttini
- 1 September 2007
- journal article
- review article
- Published by Elsevier in Autoimmunity Reviews
- Vol. 6 (8) , 553-558
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Consensus statement on the use of rituximab in patients with rheumatoid arthritisAnnals of the Rheumatic Diseases, 2007
- Rituximab for rheumatoid arthritis refractory to anti–tumor necrosis factor therapy: Results of a multicenter, randomized, double‐blind, placebo‐controlled, phase III trial evaluating primary efficacy and safety at twenty‐four weeksArthritis & Rheumatism, 2006
- Regeneration of B cell subsets after transient B cell depletion using anti‐CD20 antibodies in rheumatoid arthritisArthritis & Rheumatism, 2006
- The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: Results of a phase IIB randomized, double‐blind, placebo‐controlled, dose‐ranging trialArthritis & Rheumatism, 2006
- Update on rituximabAnnals of the Rheumatic Diseases, 2005
- B cells in rheumatoid arthritis: from hypothesis to the clinicRheumatology, 2005
- B cell therapy for rheumatoid arthritis: the rituximab (anti-CD20) experienceAnnals of the Rheumatic Diseases, 2003
- Prophylaxis of hepatitis B reactivation using lamivudine in a patient receiving rituximabAmerican Journal of Hematology, 2001
- Production of agglutinators and rheumatoid factors in plasma cells of rheumatoid and nonrheumatoid synovial tissuesArthritis & Rheumatism, 1981
- Studies on ChemotaxisInternational Archives of Allergy and Immunology, 1969